This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rossi, M. A. Articles by Ribeiro-dos-Santos, R. Search for Related Content PubMed PubMed Citation Articles by Rossi, M. A. Articles by Ribeiro-dos-Santos, R.

American Journal of Pathology, Vol 114, 209-216, Copyright © 1984 by American Society for Investigative Pathology

REGULAR ARTICLES

Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis

MA Rossi, S Goncalves and R Ribeiro-dos-Santos

In male BALB/c mice aged 5-6 weeks inoculated three times at intervals of 15 days with 1 X 10(7) epimastigote forms of the PF strain of Trypanosoma cruzi and challenged 30 days after the last inoculation with 2 X 10(4) trypomastigote forms of the Colombia strain of T cruzi (the mice were sacrificed 80-100 days after the challenge) a cardiomyopathy very similar to that observed in the chronic phase of Chagas' disease in man develops. The cardiac syndrome is characterized grossly by cardiomegaly with hypertrophy, dilatation of ventricular chambers, and thinning of the apex of the left ventricle (apical aneurysm) and microscopically by focal areas of myocytolytic necrosis and myocardial degeneration with an inflammatory response composed of mononuclear cells (predominantly macrophages and a few lymphocytes) with concurrent interstitial fibrosis and occasional myofibers containing pseudocysts. In addition, aggregated platelets and occlusive thrombi were found in small epicardial and intramyocardial vessels of infected mice as compared with controls. The potential role of intravascular platelet aggregation in the causation of focal myocardial necrosis and degeneration and apical aneurysm in experimental T cruzi cardiomyopathy in BALB/c mice is discussed.

This article has been cited by other articles:

				J. A. Marin-Neto, E. Cunha-Neto, B. C. Maciel, and M. V. Simoes Pathogenesis of Chronic Chagas Heart Disease Circulation, March 6, 2007; 115(9): 1109 - 1123. [Abstract] [Full Text] [PDF]

				J. Oliveira-Filho, L. C. Viana, R. M. Vieira-de-Melo, F. Faical, J. A. Torreao, F. A.G.A. Villar, and F. J.F.B. Reis Chagas Disease Is an Independent Risk Factor for Stroke: Baseline Characteristics of a Chagas Disease Cohort Stroke, September 1, 2005; 36(9): 2015 - 2017. [Abstract] [Full Text] [PDF]

				M. d. L. Higuchi, L. A. Benvenuti, M. Martins Reis, and M. Metzger Pathophysiology of the heart in Chagas' disease: current status and new developments Cardiovasc Res, October 15, 2003; 60(1): 96 - 107. [Abstract] [Full Text] [PDF]

				M d. L. Higuchi, S Fukasawa, T De Brito, L C Parzianello, G Bellotti, and J A F Ramires Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study Heart, September 1, 1999; 82(3): 279 - 285. [Abstract] [Full Text] [PDF]